World Economic Forum (WEF)

Pharma Outlook 2025

The environment for pharma in 2025 is diverse and challenging: New treatment options are being brought to market in ever shorter cycles.

Circular Solutions

The path to a sustainable, net-zero future for the chemical industry is paved with challenges – and also opportunities.

Circular Solutions

The path to a sustainable, net-zero future for the chemical industry is paved with challenges – and also opportunities.

Using Chemistry to Create Net-Zero Value Chains

In this interview, Charlie Tan, CEO of the Global Impact Coalition (GIC), explains the initiative’s scope and describes some key activities.

Sanofi Joins Pfizer in nonprofit Drug Distribution

Two globally oriented drugmakers, Pfizer and Sanofi, are making moves that some may interpret as attempts to allay the pharma industry‘s reputation for being “only in it for the money” but could potentially benefit poorer countries if all goes to plan.

A Pivotal Move to Net-Zero

Leading global chemical companies and the World Economic Forum (WEF) have announced that they are entering an agreement to formalize the Low-Carbon Emitting Technologies (LCET) initiative into a stand-alone entity by the end of 2023, to share early-stage risks and co-invest in developing and upscaling low-carbon emitting technologies.

Taking an Active Role in the Industry Transformation

Fernando J. Gómez, head of the Chemical and Advanced Materials Industry at the World Economic Forum (WEF), discusses the chemical-industry-related topics that are high on the WEF’s agenda.

Connected Work

We are in an increasingly volatile global climate, from health and economic crises, to trade wars on multiple fronts, to political unease, to name just a few.

BASF Hosts Climate Summit of the Chemical Industry

WEF’s Global Competitiveness Index 2018

Swiss Biotech Sector Stimulates Growth

Global Competitiveness Index

GAVI and US Merck Link on Ebola Vaccine

Drug Firms Urge Governments to Fight Superbugs

Global Competitiveness Index

Bahrain: Bringing Innovation and Industrialization to Life

Global Supply Chains and Corruption

FDA Head, Company CEOs Cheer Bumper Haul of New Drugs

Genzyme, Sanofi Reach Agreement in Principle on Takeover Terms

Monsanto, Others Agree to Invest in Agricultural Projects in Tanzania and Vietnam

Novartis CEO Joe Jimenez: Animal Health Acquisition Makes Sense

M&A Is Back As CEOs Start To Put Cash To Work

Genzyme CEO Says Proxy Fight Not Likely

Sanofi's Chris Viehbacher Sees Progress in Genzyme Talks

DSM’s Feike Sijbesma Named Humanitarian of the Year

Genzyme Acknowledges Sanofi Talks, Quick Deal Hopes Cool

Sanofi Considering Raising Bid for Genzyme

Chris Viehbacher, Henri Termeer Get Close But Will They Talk?